Ahead of the Bell: Amgen rises on Prolia approval - BusinessWeek

[INCIID News Feed]

The Money Times
<img alt="" height="1" width="1" />
Ahead of the Bell: Amgen rises on Prolia approval
BusinessWeek
Shares of Amgen Inc. rose in premarket trading Wednesday after US regulators approved Prolia, a bone drug that could help recharge the biotechnology company&#39;s sales by bringing in billions of dollars in revenue. Amgen stock rose $2.74, or 5 percent, ...
Injectable osteoporosis drug approved by FDACNN
FDA OKs Prolia for High-Risk OsteoporosisWebMD
FDA OK&#39;s Colorado-made Amgen osteoporosis drugBizjournals.com
U.S. News & World Report -Medscape -BioWorld Online
all 333 news articles &raquo;


More...